From: Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family
Name | HEK | MOR | DOR | KOR | SH-SY5Y | Literature classification |
---|---|---|---|---|---|---|
β-Funaltrexamine | off-target | Partial agonist | Partial agonist | Partial agonist |  | Mu antagonist |
BNTX | off-target | off-target | off-target | off-target | off-target | Delta antagonist |
Dynorphin A (2–13) | off-target |  | Partial agonist | Partial agonist |  | Kappa agonist |
Etonitazenyl | off-target | Partial agonist | Â | Partial agonist | Â | Mu agonist |
ICI 199,441 | off-target | Full agonist | Partial agonist | Full agonist | Â | Kappa agonist |
Nociceptin (1–13) | off-target | Partial agonist |  | Partial agonist |  | ORL1 agonist |
α-Neoendorphin |  | Partial agonist | Full agonist | Full agonist | Full agonist | Kappa agonist |
BRL-52537 | Â | Â | Partial agonist | Full agonist | Â | Kappa agonist |
BUBUC | Â | Partial agonist | Full agonist | Partial agonist | Partial agonist | Delta agonist |
DADLE | Â | Partial agonist | Full agonist | Partial agonist | Full agonist | Delta agonist |
DALDA | Â | Partial agonist | Â | Â | Full agonist | Mu agonist |
DAMGO | Â | Full agonist | Partial agonist | Partial agonist | Full agonist | Mu agonist |
DAMME | Â | Full agonist | Full agonist | Partial agonist | Full agonist | Mu/Delta agonist |
Deltorphin II | Â | Partial agonist | Full agonist | Â | Â | Delta agonist |
DIPPA | Â | Partial agonist | Partial agonist | Full agonist | Â | Kappa antagonist |
DPDPE | Â | Partial agonist | Full agonist | Partial agonist | Full agonist | Delta agonist |
DSLET | Â | Full agonist | Full agonist | Partial agonist | Full agonist | Delta agonist |
DTLET | Â | Full agonist | Full agonist | Partial agonist | Full agonist | Delta agonist |
Dynorphin A (1–13) |  | Full agonist | Full agonist | Full agonist | Partial agonist | Kappa agonist |
Dynorphin A (1–8) |  | Full agonist | Full agonist | Full agonist | Full agonist | Kappa agonist |
Dynorphin B | Â | Partial agonist | Full agonist | Full agonist | Full agonist | Kappa agonist |
Endomorphin-1 | Â | Partial agonist | Partial agonist | Â | Partial agonist | Mu agonist |
Endomorphin-2 | Â | Partial agonist | Partial agonist | Partial agonist | Full agonist | Mu agonist |
(Leu5)-Enkephalin | Â | Full agonist | Full agonist | Partial agonist | Full agonist | Mu/Delta agonist |
(Met5)-Enkephalin | Â | Full agonist | Full agonist | Partial agonist | Full agonist | Mu/Delta agonist |
GR 89696 | Â | Partial agonist | Partial agonist | Full agonist | Full agonist | Kappa agonist |
ICI 204,448 | Â | Partial agonist | Partial agonist | Full agonist | Full agonist | Kappa agonist |
Levallorphan | Â | Â | Partial agonist | Partial agonist | Â | Partial Mu/delta agonist |
Morphiceptin | Â | Partial agonist | Â | Â | Partial agonist | Mu agonist |
Nalbuphine | Â | Partial agonist | Partial agonist | Partial agonist | Â | Partial Mu/kappa agonist |
Naloxonazine | Â | Â | Â | Partial agonist | Â | Mu antagonist |
Naloxone HCl | Â | Â | Â | Â | Â | Opioid antagonist |
Naloxone methiodide | Â | Â | Â | Â | Â | Opioid antagonist |
Naltrexone | Â | Â | Â | Partial agonist | Â | Opioid antagonist |
Naltriben | Â | Â | Â | Â | Â | Delta antagonist |
Naltrindole | Â | Â | Â | Â | Â | Delta antagonist |
N-Benzylnaltrindole | Â | Â | Partial agonist | Partial agonist | Â | Delta antagonist |
N-MPPP | Â | Partial agonist | Partial agonist | Full agonist | Â | Kappa agonist |
NNC 63-0532 | Â | Partial agonist | Partial agonist | Partial agonist | Full agonist | ORL1 agonist |
Nociceptin | Â | Â | Â | Partial agonist | Â | ORL1 agonist |
Nor-Binaltorphimine | Â | Â | Â | Â | Â | Kappa antagonist |
(−)-Norcodeine |  | Partial agonist |  | Partial agonist | Partial agonist | Opioid antagonist |
Salvinorin A | Â | Partial agonist | Â | Full agonist | Â | Kappa agonist |
SKF10047 | Â | Â | Partial agonist | Partial agonist | Â | Opioid agonist/antagonist |
SNC 121 | Â | Â | Partial agonist | Partial agonist | Partial agonist | Delta agonist |
SNC 80 | Â | Partial agonist | Partial agonist | Partial agonist | Partial agonist | Delta agonist |
Syndyphalin SD-25 | Â | Full agonist | Partial agonist | Partial agonist | Partial agonist | Mu agonist |
TAPP | Â | Partial agonist | Partial agonist | Partial agonist | Full agonist | Mu agonist |
Tramadol | Â | Partial agonist | Â | Â | Â | Weak Mu agonist |
(−)-U-50488 |  | Partial agonist | Partial agonist | Full agonist |  | Kappa partial agonist |
(+)-U-50488 | Â | Â | Â | Full agonist | Â | Kappa partial agonist |
U-50,488H | Â | Partial agonist | Partial agonist | Full agonist | Â | Kappa agonist |
U-54494A | Â | Partial agonist | Partial agonist | Partial agonist | Â | Kappa agonist |
U-62066 | Â | Partial agonist | Â | Full agonist | Â | Kappa agonist |
U-69593 | Â | Partial agonist | Partial agonist | Full agonist | Â | Kappa agonist |